Surgery Partners (SGRY) Files $431.3M Common Stock IPO

Surgery Partners, Inc. (Nasdaq: SGRY) filed a registration with the U.S. SEC for an IPO of its Common Stock. The proposed maximum offering price is $431.25 million. The company plans to list on the Nasdaq under the ticker, SGRY.

The offering is being made via BofA Merrill Lynch, Goldman, Sachs & Co., Jefferies, Citigroup, Morgan Stanley, Credit Suisse, Raymond James, Stifel, and RBC Capital Markets.

Financial commentary: "Our pro forma revenue for 2014 was $871.2 million, which represents a compound annual growth rate (“CAGR”) of approximately 83% compared to revenue of $260.2 million for the year ended December 31, 2012. For the six months ended June 30, 2015, our revenue was $457.0 million, compared to revenue of $147.3 million for the same period during 2014. In 2014, on a pro forma basis, we experienced a net loss of $8.6 million as compared to net income of $1.9 million for the year ended December 31, 2012. For the six months ended June 30, 2015, we experienced a net loss of $12.2 million as compared to $4.7 million for the same period during 2014. Our pro forma Adjusted EBITDA was $153.3 million for 2014, representing an approximately 74% CAGR when compared to Adjusted EBITDA of $51.0 million for the year ended December 31, 2012. For the six months ended June 30, 2015, our Adjusted EBITDA was $74.4 million as compared to Adjusted EBITDA of $30.0 million for the same period during 2014."

Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high quality, cost effective solutions for surgical and related ancillary care in support of its patients and physicians.

You May Also Be Interested In

• SpaceX prices IPO at $135 per share for June 12 Nasdaq debut
• Atossa Therapeutics raises $4.5 million in registered direct offering
• Edesa Biotech raises $3.5 million in private placement led by CEO